PTK2 and mantle cell lymphoma: In particular, it has been demonstrated that MCL cells, upon culture with stromal cells, show an activation of pathways such as NF‐kB, Akt, c‐Myc, Cyclin‐D and p42/44, all associated with cancer progression, and FAK inhibition abrogates the activation of all these effectors.